Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,875 | 2 | 92.6% |
| Travel and Lodging | $284.37 | 3 | 5.4% |
| Food and Beverage | $104.19 | 3 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $4,888 | 3 | $0 (2017) |
| EMD Serono Research & Development Institute | $284.37 | 3 | $0 (2017) |
| GENZYME CORPORATION | $91.54 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $67.73 | 1 | GENZYME CORPORATION ($67.73) |
| 2017 | $5,196 | 7 | EMD Serono, Inc. ($4,888) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $67.73 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/07/2017 | EMD Serono, Inc. | Rebif (Biological) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: Neurology | ||||||
| 07/07/2017 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Neurology | ||||||
| 06/20/2017 | EMD Serono, Inc. | Rebif (Biological) | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| Category: Neurology | ||||||
| 06/14/2017 | EMD Serono Research & Development Institute | Mavenclad (Biological) | Travel and Lodging | Cash or cash equivalent | $108.78 | General |
| Category: Neurology | ||||||
| 06/13/2017 | EMD Serono Research & Development Institute | Mavenclad (Biological) | Travel and Lodging | Cash or cash equivalent | $103.48 | General |
| Category: Neurology | ||||||
| 06/13/2017 | EMD Serono Research & Development Institute | Mavenclad (Biological) | Travel and Lodging | Cash or cash equivalent | $72.11 | General |
| Category: Neurology | ||||||
| 02/24/2017 | GENZYME CORPORATION | LEMTRADA (Drug), AUBAGIO, MS DISEASE STATE | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
About Dr. Gary Birnbaum, M.D
Dr. Gary Birnbaum, M.D is a Neurology healthcare provider based in Golden Valley, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902850159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Birnbaum, M.D has received a total of $5,264 in payments from pharmaceutical and medical device companies, with $67.73 received in 2019. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($4,875).
Practice Information
- Specialty Neurology
- Location Golden Valley, MN
- Active Since 05/20/2006
- Last Updated 07/11/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902850159
Products in Payments
- Rebif (Biological) $4,888
- Mavenclad (Biological) $284.37
- AUBAGIO (Drug) $67.73
- LEMTRADA (Drug) $23.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Golden Valley
Dr. Jonathan Calkwood, M.d, M.D
Neurology — Payments: $1.0M
Jessica Stulc, Md, MD
Neurology — Payments: $339,019
Dr. Irfan Altafullah, M.b., B.s, M.B., B.S
Neurology — Payments: $203,754
Dr. Jessica Heiring
Neurology — Payments: $194,211
Dr. Joanne Rogin, M.d, M.D
Neurology — Payments: $120,981
Dr. Randall Schapiro, M.d, M.D
Neurology — Payments: $67,098